Navigation Links
Pharmaceutical and Medical Device Patent Portfolio Acquisition Opportunities from ICAP Patent Brokerage

NEW YORK, Sept. 4, 2013 /PRNewswire/ -- ICAP Patent Brokerage announces innovative pharmaceutical and medical device patent portfolios available for sale via private brokerage.


"­­­­­­­­­­­­­­­­­­­­­­­­­­We are thrilled to offer such strong patent portfolios disclosing key advancements for the medical and pharmaceutical industry. The cutting-edge inventions developed in this space and now available for sale have endless possibilities – most importantly improved medical care and enhanced quality of life – when matched with the right buyer," says Dean Becker, CEO of ICAP Patent Brokerage.

Patent Portfolios for Sale
The assets available for sale disclose key innovations relevant to these exciting technology sectors, including:

  • Material for Orthopedic Applications
  • Enhanced Topical Analgesic Cream
  • and more!

Click here to see a complete catalog of the pharmaceutical and medical device patent portfolios available for sale.

To learn more about the assets available for sale:
Contact Paul Greco of ICAP Patent Brokerage at (212) 815-6692 or via email at

Follow us on Twitter (@ICAP_Auction_IP) and join our LinkedIn group.

About ICAP Patent Brokerage

ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.

About ICAP

ICAP is a leading markets operator and provider of post trade risk mitigation and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through its post trade risk mitigation and information services ICAP helps customers manage and mitigate risks in their portfolios. For more information, go to

SOURCE ICAP Patent Brokerage
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
2. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
3. Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
4. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
5. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
6. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
7. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
8. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
9. Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
10. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
11. Pharmaceutical Industry Relies on Medical Science Liaisons to Generate Value across a Diverse Set of Customers
Post Your Comments:
(Date:12/1/2015)... --> --> ... by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, Vaccines, (Therapeutic ... Analysis - Global Forecast to 2020", published by MarketsandMarkets, the ... Million by 2020 from USD 40,281.6 Million in 2015, at ... Browse 37 market data T ...
(Date:12/1/2015)... 2015 Assurex Health, Inc. today announced ... healthcare providers an expanded range of options in ... from depression, anxiety, bipolar disorder, posttraumatic stress disorder ... i .   --> ... addition of two new drug classes, 17 FDA-approved ...
(Date:12/1/2015)... , Dec. 1, 2015  Six months of adjunctive metformin ... type 1 diabetes, according to new research from T1D ... it may have a beneficial effect on measures of obesity, ... issue of the Journal of the American Medical Association ... the effect of metformin on overweight and obese adolescents with ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 02, 2015 , ... Ruth Pearson was struggling. She had been laid off ... assistance and quickly losing hope of recovering her former life, Pearson was desperate for ... attending a women’s retreat when she experienced a particularly impactful worship service. Without help ...
(Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday ... to NASDAQ to educate the personnel on spinal decompression therapy and offer his ... a nonsurgical procedure. The benefits come from creating negative intradiscal pressure which is ...
(Date:12/1/2015)... ... December 01, 2015 , ... Henderson, a ... to receive Gigabit Internet through a partnership this year with Aeneas Internet and ... is an attractive destination for entrepreneurs who want to build a business. Whether ...
(Date:12/1/2015)... ... , ... Florida Hospital Tampa is the first health care provider in the region ... , vBloc® Therapy is a vagal blocking therapy, delivered via the Maestro® System, for the ... (BMI) of at least 40 to 45 kg, or a BMI of at least 35 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Califia ... today announced that its iconic bottle has won top honors in Beverage World Magazine’s ... The Company also announced that it has been selected as a 2015 U.S.A. Taste ...
Breaking Medicine News(10 mins):